SINOPHARM
China National Biotec Group (CNBG) - COVID-19 In Vitro Diagnostic Medical Devices
China National Biotec Group Company Limited (referred to as Sinopharm CNBG), a subsidiary of China National Pharmaceutical Group Co., Ltd. Sinopharm CNBG was the 6th vaccine to be authorized by the World Health Organization (WHO) for its emergency listing, receiving WHO validation for safety, efficacy and quality. It is produced by the Beijing Bio-Institute of Biological Products Co Ltd (BIBP), a subsidiary of Sinopharm CNBG.
| Product Name: |
| 1) Nucleic Acid Reagents: PCR and LAMP |
| 2) Antigen Reagents: Nasopharyngeal and Saliva (lollipops type) |
As an authorized partner, we are facilitating the product registration of Sinopharm reagents, undertake all commercial activities related to import, sale and distribution of the products to Malaysia, Thailand, Singapore, Dubai, Saudi Arabia, Turkey and Myanmar.
1) ANTIGEN TEST KIT
[Product Name] : SARS-CoV-2 Antigen test kit (Colloidal Glod)
2) NEUTRALIZING ANTIBODY DETECTION KIT
[Product Name] : Novel Coronavirus 9SARS-CoV-2) Neutralizing Antibody Detection Kit (ELISA)
3) NUCLEIC ACID REAGENTS
a) Polymerase Chain Reaction (PCR)
[Product Name] : Novel Coronavirus 2019-nCoV Nucleic Acid Detection Kit (Real Time PCR)
PCR is technique used to "amplify" - copy - small segments of DNA. Sometimes called "molecular photocopying," Often heralded as one of the most important scientific advances in molecular biology, PCR revolutionized the study of DNA . PCR was invented in 1983 by the American biochemist Kary Mullis at Cetus Corporation; Mullis and biochemist Michael Smith, who had developed other essential ways of manipulating DNA,[1] were jointly awarded the Nobel Prize in Chemistry in 1993.
b) Loop-mediated isothermal amplification (LAMP)
[Product Name] : Novel Coronavirus 2019-nCoV Rapid Detection Kit (LAMP)
LAMP invented in 2000 of testing using nucleic amplification which is growing in use as it is comparatively more efficient and cost-effective than PCR testing. Like PCR, LAMP testing requires the RNA to be extracted from the sample before being amplified.
Two technologies of ART and PCR have their own advantages and disadvantages. The former is convenient, fast, cheap and suitable for use at home, but it is less accurate and only be used for the purpose of wide scanning, while the latter is inconvenient, long process and expensive, it needs to be operated by professional technicians in the laboratory, its accuracy is the final confirmation of infected patients.
LAMP is a method which is able to achieve the accuracy of PCR with a speed comparable to ART and cost effective.
Sinopharm's RT-LAMP manufacturing with quality assurance and technology invented by Oxford University technology, enterprise version (one portable heating machine at constant temperature of 65°C) can be carried out on-site on a wide scale (96 samples simultaneously) with results made available within 30 minutes, which is suitable for border controls of country e.g: airport, seaports or transit corridor. home version for 1 or 4 samples to cater to travelers or family needs too. Products are reliable, accurate, fast, convenient and affordable. It will be useful as part of Safe Management Measures when resuming workplace/public activities, which will bring about obvious economic benefits to the countries and public. RT-LAMP solutions will decentralize Covid19 testing efforts across the country, allowing improved access and shorter turnaround times. This enables more people to get tested and curb the infection spread through early detection.
